With the emergence of positron emission tomography (PET) from research laboratories into routine clinical use, it is important to redefine the most appropriate use of each imaging technique. The aim of this review article is to show the potential of PET in oncology. We discuss the most promising indications and the perspectives for the future. We will also point out the shortcomings and the important questions to be answered before fully considering PET as a necessary tool in the day-to-day practice of oncology. Although many studies have documented the high accuracy of F-18-FDG PET for the detection and staging of malignant tumours and for the monitoring of therapy results in these patients, it is very important to assess the impact of the technique on patient outcome and to show cost-effectiveness from the societal viewpoint. (C) 2003 Elsevier Ltd. All rights reserved.
机构:
Washington Univ, Sch Med, Dept Radiat Oncol, 4921 Parkview Pl,660 South Euclid Ave, St Louis, MO 63110 USAWashington Univ, Sch Med, Dept Radiat Oncol, 4921 Parkview Pl,660 South Euclid Ave, St Louis, MO 63110 USA
Rao, Yuan James
Grigsby, Perry W.
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Sch Med, Dept Radiat Oncol, 4921 Parkview Pl,660 South Euclid Ave, St Louis, MO 63110 USAWashington Univ, Sch Med, Dept Radiat Oncol, 4921 Parkview Pl,660 South Euclid Ave, St Louis, MO 63110 USA